Background Beneficial effects of aspirin and non-aspirin nonsteroidal anti-inflammatory
drugs (NSAIDs) against recurrent colorectal adenomas have been documented in …

Background Patients with familial adenomatous polyposis have a nearly 100 percent risk of
colorectal cancer. In this disease, the chemopreventive effects of nonsteroidal …

Abstract Selective cyclooxygenase (COX)-2 inhibitors (coxibs) were developed as one of the
anti-inflammatory drugs to avoid the various side effects of non-steroidal anti-inflammatory …

Colorectal cancer (CRC) is presently one of the most common causes of cancer‐related
death in our setting and affects a great number of people each year. Screening strategies …

Background—Observational studies and randomized trials have reported increased
cardiovascular risk associated with cyclooxygenase-2 inhibitors. Prior placebo-controlled …

Non-steroidal anti-inflammatory drugs (NSAIDs) are the most widely used therapeutic
agents in the treatment of pain, inflammation and fever. They may also have a role in the …

Cancer chemoprevention is a new approach in the management of cancer. Traditional
cytotoxic chemotherapeutic approaches cannot cure most advanced solid malignancies …

Coxibs, including celecoxib, and other nonsteroidal anti-inflammatory drugs (NSAID),
including aspirin, are among the most promising cancer chemopreventive agents in …

Objective: To prospectively examine the association between non-steroidal anti-
inflammatory drugs (NSAIDs) use (including dose and dosage schedule) and the recurrence …

Colorectal cancer is the second leading cause of death from cancer in the United States.
Differences in dietary habits and lifestyles among populations in different geographic …